After several months of work and remote meetings, due to the contingency caused by COVID-19, the human team behind VOYAGER met on Friday, November 20 at Noi Hotel to participate in a real-time demonstration. The meeting became an instance to analyze the current scope of the project and its future projections.

Álvaro Riquelme, doctor and Product Manager of the system, was in charge of showcasing the proposal’s processing capabilities using speech recognition, deep learning and cloud computing. This technology, applied by UNIT, is responsible for generating a structured electronic medical record for each patient, centralizing and systematizing important information regarding their diagnosis and treatment.

“The creation of this interdisciplinary team has allowed us to shape VOYAGER based on knowledge from various disciplines, helping us to understand the problem and landing a solution concept that is the one we have in the form of a demo today,” explained Dr. Riquelme.

VOYAGER: A public-private collaboration

Aldo Diez de Medina, director of San Vicente de Tagua Tagua’s Hospital, highlighted the importance of the collaboration developed by UNIT, Roche and the establishment he runs. “Companies are usually focused on generating profits, so it is pleasant to be able to see the evolution of the system and work with companies that are supporting public health,” said the manager.

Alex Pozo, medical technologist and director of Supplies at the hospital, referred to the importance of improving treatment guidelines for these types of diagnoses, a goal that VOYAGER is on track to meet.

“It is a tool that is based on artificial intelligence and machine learning to manage the treatment of chronic patients. We are talking about people over 70 years of age, so it is a patient profile who has a hard time adhering to their treatment and that needs a constant support network to be able to comply with it”, Pozo explained.

For her part, Cecilia Acuña, who is Roche Diagnostics Innovation Lead & Patient Outcomes Consultant, assured that “I was very impressed with the voice data entry system. I think it is a tool that has the potential to revolutionize the work of the clinical area”.

“Nowadays a big complaint from doctors is the large amount of time they must dedicate to the administrative area. VOYAGER manages to solve this problem, to allow health professionals to dedicate this time to what really matters, which is, in the first instance, to talk with patients and then, of course, treat them ”, pointed out Acuña.

The project uses artificial intelligence to improve clinical care protocols for patients with multifactorial diseases, whose condition is essentially chronic. Among the most common pathologies is diabetes, which has been one of the major focuses of the project.

“For us, these projects are fundamental because they are a way to innovate and develop a complete and comprehensive solution, something that helps not only the patient, but also the health team responsible for their treatment,” said Andrea Vergara, New Business Models Manager of the Diabetes area of ​​Roche.

In this way, the piloting of the system within the Creasphere program is aimed at being a success story worldwide, to benefit millions of patients with diabetes and other multifactorial diseases in adherence to their treatment.